FDA Approves Birch Triterpenes Topical Gel for Epidermolysis Bullosa : vimarsana.com

The FDA’s approval of Chiesi Global Rare Diseases’ topical gel marks the first approval for the variant of EB known as JEB.

Related Keywords

United States , America , Giacomo Chiesi , Brett Kopelan , Drug Administration , Chiesi Global Rare Diseases , Junctional Epidermolysis Bullosa , Dystrophic Epidermolysis Bullosa , Butterfly Disease , Butterfly Disease , Fda , Approval , Epidermolysis Bullosa , Eb , Deb , Birch Triterpenes , Topical Gel , Filsuvez ,